Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | PPM1B | O75688 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.32 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | PPP5C | P53041 | 1/20 | 0.32 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19574052 | 0.85 | KDM4E (0.31) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL1075162 | 0.84 | — | — | |
| SCHEMBL3387123 | 0.84 | — | — | |
| SCHEMBL13309236 | 0.84 | — | — | |
| SCHEMBL14435544 | 0.84 | — | — | |
| SCHEMBL21185140 | 0.74 | — | — | |
| SCHEMBL13451412 | 0.74 | — | — | |
| SCHEMBL21396628 | 0.73 | — | — | |
| SCHEMBL6357085 | 0.72 | — | — | |
| SCHEMBL851839 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1234047-C | Chemical amplification light resistance agent compsn. | AMERICAN EVERBRIGHT CORP (US) | 2005-12-28 | — | — | CN | disclosed |
| CN-1228359-C | High molecular polymer of chemical amplification type light resistance agent compsn. | AMERICAN EVERBRIGHT INC (US) | 2005-11-23 | — | — | CN | disclosed |
| CN-1197852-C | High molecular monomer of chemical amplification type light resistance agent compson. | AMERICAN EVERBRIGHT INC (US) | 2005-04-20 | — | — | CN | disclosed |
| US-6720430-B2 | HETEROCYCLIC LACTON ACRYLATE ESTER MONOMERS; ISOBENZOFURAN ACRYLATE ESTERS; 4,7-METHANOISOBENZOFURAN ACRYLATE ESTERS; 4,7-EPOXYISOBENZOFURAN ACRYLATE ESTERS | EVERLIGHT USA, INC. | 2004-04-13 | — | — | US | disclosed |
| US-6703178-B2 | COMPRISES A POLYMER CONTAINING A NOVEL LACTONE ALICYCLIC UNIT; WELL-BALANCED OUTCOME OF ETCHING RESISTANCE AND SUBSTRATE ADHESION | EVERLIGHT USA, INC. | 2004-03-09 | — | — | US | disclosed |
| CN-1462909-A | Chemical amplification light resistance agent compsn. | AMERICAN EVERBRIGHT CORP (US) | 2003-12-24 | — | — | CN | disclosed |
| CN-1462747-A | High molecular monomer of chemical amplification type light resistance agent compson. | AMERICAN EVERBRIGHT INC (US) | 2003-12-24 | — | — | CN | disclosed |
| CN-1462757-A | High molecular polymer of chemical amplification type light resistance agent compsn. | AMERICAN EVERBRIGHT INC (US) | 2003-12-24 | — | — | CN | disclosed |
| US-20030232270-A1 | CHEMICAL AMPLIFIED PHOTORESIST COMPOSITIONS | EVERLIGHT USA, INC. (US) | 2003-12-18 | — | — | US | disclosed |
| US-20030229234-A1 | Monomer for chemical amplified photoresist compositions | EVERLIGHT USA, INC. (US) | 2003-12-11 | — | — | US | disclosed |
| US-6639035-B1 | Acrylate copolymers including fused ring monomers; adhesive; hydrophilic; heat and dry etch resistance; ultraviolet radia-tion transparency | EVERLIGHT USA, INC. | 2003-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030229234-A1 | Monomer for chemical amplified photoresist compositions | H1-0, CCNA1, CCNT1 | KDM4E 2643/4885GMNN 1140/4885PPM1B 3028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.